Costs and effects of paliperidone extended release compared with alternative oral antipsychotic agents in patients with schizophrenia in Greece: a cost effectiveness study

Costs and effects of paliperidone extended release compared with alternative oral antipsychotic agents in patients with schizophrenia in Greece: a cost effectiveness study

Show other versions (1)

<p>Abstract</p> <p>Correction to Geitona M, Kousoulakou H, Ollandezos M, Athanasakis K, Papanicolaou S and Kyriopoulos I: Costs and effects of paliperidone extended release compared with alternative oral antipsychotic agents in patients with schizophrenia in Greece: a cost effectiv...

Full description

Bibliographic Details
Main Authors: Papanicolaou Sotiria, Athanasakis Kostas, Ollandezos Markos, Kousoulakou Hara, Geitona Maria, Kyriopoulos Ioannis
Format: Article
Language:English
Published: BMC 2009-06-01
Series:Annals of General Psychiatry
Online Access:http://www.annals-general-psychiatry.com/content/8/1/15
Description
Summary:<p>Abstract</p> <p>Correction to Geitona M, Kousoulakou H, Ollandezos M, Athanasakis K, Papanicolaou S and Kyriopoulos I: Costs and effects of paliperidone extended release compared with alternative oral antipsychotic agents in patients with schizophrenia in Greece: a cost effectiveness study. <it>Annals of General Psychiatry </it>2008, 7:16. This correction reports changes in the values listed for Ziprasidone and Aripiprazole in Table Ten.</p>
ISSN:1744-859X

Similar Items